Looking back at how the Obama/Biden administration prepared for a possible anthrax attack, they entered into a no-bid contract with a company controlled by billionaire Democratic contributor Ron Perelman.
Siga Technologies developed an experimental anthrax drug with the aid of federal money. Yes, we financed them. There wasn’t even any proof that the drug would work.
Siga was awarded a no-bid contract for 1.7 million doses of the drug for a whopping 433 million dollars. That’s $255 a dose.
There were serious concerns about buying a drug that may not work that the taxpayers funded and then paid Perelman 433 million dollars.
Did we need these drugs? After all, anthrax is a very serious matter. The truth is we already had enough anthrax vaccine to immunize every man woman and child in America with some left over. Furthermore, the drug does work, and it cost the taxpayers just $3 a dose.
So, tell me the truth, do you really think you could depend on Joe Biden to handle a crisis as large as the DTMNBN? (Disease That Must Not Be Named) Would you really risk such a scenario, especially after the Obama/Biden administration did nothing on the H1N1 epidemic until over 1,000 people died?
That’s about five times the deaths we currently have, and the DTMNBN is much worse than the H1N1 flu.
Senior officials have taken unusual steps to secure the contract for New York-based Siga Technologies Inc., whose controlling shareholder is billionaire Ronald O. Perelman, one of the world’s richest men and a longtime Democratic Party donor.
When Siga complained that contracting specialists at the Department of Health and Human Services were resisting the company’s financial demands, senior officials replaced the government’s lead negotiator for the deal, interviews and documents show.
When Siga was in danger of losing its grip on the contract a year ago, the officials blocked other firms from competing.
Siga was awarded the final contract in May through a “sole-source” procurement in which it was the only company asked to submit a proposal. The contract calls for Siga to deliver 1.7 million doses of the drug for the nation’s biodefense stockpile. The price of approximately $255 per dose is well above what the government’s specialists had earlier said was reasonable, according to internal documents and interviews.